Posts by Jason Lutjen

This study will compare two implementation strategies, one vertical and one horizontal, to improve interagency collaboration between the criminal justice and community behavioral health sectors. The vertical strategy will train all units of the community simultaneously, while the horizontal strategy will initially train one unit as a prototype, and then help to train other units…

This study will use a cluster-randomized stepped-wedge type-2 hybrid effectiveness-implementation design to test the impact of a new implementation intervention (Opioid Court REACH; Research on Evidence-Based Approaches to Court Health) in improving opioid cascade of care, public health, and public safety outcomes. This intervention would allow the new opioid intervention court model in New York…

The goal of this study is to conduct a Type 1 hybrid effectiveness-implementation study of seven jails in Massachusetts that deliver all FDA-approved MOUDs (naltrexone, buprenorphine, methadone) to produce findings with implications for policies for OUD in criminal justice settings. This research will focus on (1) post-release recidivism, overdoses, and MOUD initiation, engagement, and retention,…

This trial will examine the implementation of an innovative pretreatment model for medications for opioid use disorder (MOUD) using telehealth and/or peer navigators for women transitioning from jail to the community in Kentucky. This project aims to reduce opioid relapse and overdose among high-risk women during community reentry through increasing initiation and maintenance of MOUD.

This proposed randomized control trial will test the pharmacotherapy adherence (number of monthly injections received) of extended-release buprenorphine (XR-B) versus extended-release naltrexone (XR-NTX) among adults with opioid use disorder (OUD) who are nearing release from county jails in Maryland. The results of this trial will have substantial public health implications as most individuals with OUD…

This study will test an adapted version of Recovery Management Checkups (RMC), which provide treatment linkage, retention support, and re-linkage, among released incarcerated individuals with opioid use disorder (OUD), to determine if this type of ongoing support improves the effectiveness of treatment engagement and recovery compared to the original RMC intervention.

This study used a microsimulation model to analyze the potential differences in rates of post-release opioid-related overdoses in Rhode Island resulting from three specific interventions: extended-release (XR) naltrexone only, access to all three medications for opioid use disorder (MOUD) (methadone, buprenorphine, XR-naltrexone), and standard of care (limited access to MOUD). Based on this model, over…

This study among 92 individuals who use drugs in Providence, Rhode Island, examined the relationship between drug users and suppliers, and how it is connected to overdose risk. Results indicate that greater substance harm reduction in Providence is associated with a long-term and trusted relationship between users and dealers.

This study used a predictive model to examine the potential impact of screening and treatment for opioid use disorder (OUD) within prisons and jails on opioid-related mortality after release. The model results indicate that widespread uptake of screening and treatment both within prisons and jails and post-release would substantially reduce opioid-related deaths by thousands.